DK509886A - Udtrykkelsesforoegende dna-sekvenser - Google Patents

Udtrykkelsesforoegende dna-sekvenser

Info

Publication number
DK509886A
DK509886A DK509886A DK509886A DK509886A DK 509886 A DK509886 A DK 509886A DK 509886 A DK509886 A DK 509886A DK 509886 A DK509886 A DK 509886A DK 509886 A DK509886 A DK 509886A
Authority
DK
Denmark
Prior art keywords
expression
dna sequences
enhancing
inducing dna
bacterial cell
Prior art date
Application number
DK509886A
Other languages
English (en)
Other versions
DK509886D0 (da
Inventor
Alan Sloma
Rosalind C Lee
Janice Pero
Original Assignee
Bioteknika International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioteknika International filed Critical Bioteknika International
Publication of DK509886D0 publication Critical patent/DK509886D0/da
Publication of DK509886A publication Critical patent/DK509886A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411Amylases
    • C12N9/2414Alpha-amylase (3.2.1.1.)
    • C12N9/2417Alpha-amylase (3.2.1.1.) from microbiological source
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK509886A 1985-10-25 1986-10-24 Udtrykkelsesforoegende dna-sekvenser DK509886A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79135085A 1985-10-25 1985-10-25
US06/921,343 US5017477A (en) 1985-10-25 1986-10-20 Enhancing DNA sequencies derived from the sacQ gene

Publications (2)

Publication Number Publication Date
DK509886D0 DK509886D0 (da) 1986-10-24
DK509886A true DK509886A (da) 1987-04-26

Family

ID=27121148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK509886A DK509886A (da) 1985-10-25 1986-10-24 Udtrykkelsesforoegende dna-sekvenser

Country Status (6)

Country Link
US (1) US5017477A (da)
EP (1) EP0227260B1 (da)
AT (1) ATE88216T1 (da)
CA (1) CA1313152C (da)
DE (1) DE3688282T2 (da)
DK (1) DK509886A (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602793B1 (fr) * 1986-08-18 1989-04-07 Pasteur Institut Sequence d'adn exercant une fonction se manifestant par une surproduction de proteines exocellulaires par diverses souches de bacillus, et vecteurs contenant cette sequence
DE3711883A1 (de) * 1987-04-08 1988-10-27 Merck Patent Gmbh Genetische kontrolleinheit und klonierungs- und expressionssystem
FR2621597B1 (fr) * 1987-07-24 1992-07-31 Pasteur Institut Procede de clonage et d'expression de genes codant pour des proteines constituant des edifices fonctionnels organises
FR2618453A1 (fr) * 1987-07-24 1989-01-27 Pasteur Institut Procede de clonage et d'expression de genes codant pour des proteines constituant des edifices fonctionnels organises
DE3824827A1 (de) * 1988-07-21 1990-02-01 Henkel Kgaa Plasmide zur erzeugung von alpha-amylase in bacillus
EP0544707A1 (en) * 1990-08-13 1993-06-09 Alko Limited HYBRID $g(a)-AMYLASE PROMOTERS
US5294542A (en) * 1991-03-19 1994-03-15 Omnigene, Inc. Residual protease-III
DE69434807T2 (de) * 1993-02-26 2007-03-29 Novozymes A/S Methode und system zur erhöhten produktion von kommerziell wichtigen exoproteinen in gram-positiven bakterien
EP2000477A1 (en) * 2007-06-07 2008-12-10 DSM IP Assets B.V. Increased production of a target product via stabilization of mRNA
CN101679490B (zh) * 2007-06-07 2014-05-07 帝斯曼知识产权资产管理有限公司 通过mRNA的稳定化提高目标产物的生产
US20240318188A1 (en) 2021-06-24 2024-09-26 Basf Se Bacillus licheniformis host cell for production of a compound of interest with increased purity
CN117813317A (zh) 2021-06-24 2024-04-02 巴斯夫欧洲公司 改良的芽孢杆菌生产宿主

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61982A (en) * 1980-02-15 1984-01-31 Cpc International Inc Genetically engineered microorganisms for massive production of amyloytic enzymes and process for preparing same using the corresponding recombinant dnas containing amylase coding genes
EP0093121A4 (en) * 1981-08-21 1984-02-09 University Patents Inc IMPROVED EXPRESSION OF PROTEIN SYNTHESIS IN SI (E. COLI).
EP0074553A3 (en) * 1981-09-11 1985-01-09 The University Of Rochester Method of increasing the yield of a product by altering a microorganism
ATE48156T1 (de) * 1982-11-01 1989-12-15 Miles Inc Verfahren zur heterologen klonierung eines gens in einem bacillus-mikroorganismus.
US4554250A (en) * 1983-06-30 1985-11-19 E. R. Squibb & Sons, Inc. Method of increased production of penicillin acylase and plasmid employed therein
CA1311429C (en) * 1983-07-06 1992-12-15 Vasantha Nagarajan Vector for polypeptides in bacilli
EP0146743B1 (en) * 1983-11-08 1992-07-29 Teijin Limited Gene fragments derived from human immunoglobulin gene
EP0149241B1 (en) * 1983-12-28 1991-03-27 Agency Of Industrial Science And Technology Dna base sequence containing regions involved in the production and secretion of a protein, recombinant dna including the whole or a part of the dna base sequence, and method of producing proteins by use of the recombinant dna
JPH0789930B2 (ja) * 1984-03-08 1995-10-04 大正製薬株式会社 ウイルス性転写促進配列
CA1275954C (en) * 1984-08-31 1990-11-06 Hing Cheug Wong 3'-expression enhancing fragments and method
GB8521753D0 (en) * 1985-09-02 1985-10-09 Green M Oxide bronze materials

Also Published As

Publication number Publication date
ATE88216T1 (de) 1993-04-15
DE3688282T2 (de) 1993-11-18
DE3688282D1 (de) 1993-05-19
EP0227260B1 (en) 1993-04-14
CA1313152C (en) 1993-01-26
EP0227260A1 (en) 1987-07-01
DK509886D0 (da) 1986-10-24
US5017477A (en) 1991-05-21

Similar Documents

Publication Publication Date Title
DK320686D0 (da) Ekspressionskontrolsekvenser
FI831818L (fi) Mikrobiologiskt framstaellda - och -interferoner, dessa interferoner kodande dna-sekvenser, dennagenetiska information innehaollande mikroorganismer och deras framstaellningsfoerfarande
DK509886A (da) Udtrykkelsesforoegende dna-sekvenser
IE812224L (en) Interferon
AU615413B2 (en) Production of thrombin inhibitors
GB8626878D0 (en) Dna
ES8800691A1 (es) Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip)
BG45047A3 (bg) Метод за получаване на изопеницилин н синтетазна активност в гостоприемникова клетка
IL78270A0 (en) Dedicated ribosomes and their use
ATE66250T1 (de) In bacillus-subtilis verwendbare expressionsplasmide.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment